Latest news posts

All news posts

BioStock: Sunday interview with Annette Agerskov

Enorama Pharmas Vice President on the Market Application Agreement

Finished the final studies of our first two products

The share rises 25 per cent.

A milestone: we celebrate our test results

All the tests of the company's nicotine gum are now completed with positive results.

The second bioequivalence study is completed

The result is positive and means that all studies required for pharmaceutical registration are completed.

BioStock: Enorama Pharma about the US agreement

Interview with Vice President, Annette Agerskov, about the new collaboration and what it means for Enorama Pharma.

BioStock: Sunday interview with Annette Agerskov

We meet Annette Agerskov who has worked with chewing gum for most of her professional life.

Aizant - FDA approved key partner for Enorama Pharma

With Aizant's production capacity and specialist expertise, the partnership looks at least on paper as a home run for Enorama.

No financial surprises in the interim report

As expected, the company has no products on the market and therefore shows no revenue.